Cargando…
The impact of prescription opioids on all-cause mortality in Canada
An influential study from the United States generated considerable discussion and debate. This study documented rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century, with clear linkages of all-cause mortality to increasing rates of poisonings, suicides and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968006/ https://www.ncbi.nlm.nih.gov/pubmed/27476513 http://dx.doi.org/10.1186/s13011-016-0071-4 |
_version_ | 1782445604273651712 |
---|---|
author | Imtiaz, Sameer Rehm, Jürgen |
author_facet | Imtiaz, Sameer Rehm, Jürgen |
author_sort | Imtiaz, Sameer |
collection | PubMed |
description | An influential study from the United States generated considerable discussion and debate. This study documented rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century, with clear linkages of all-cause mortality to increasing rates of poisonings, suicides and chronic liver disease deaths. All of these causes of deaths are strongly related to the use of legal and illegal substances, but the study stressed the importance of prescription opioids. Given the similarities between the United States and Canada in prescription opioid use, the assessment of similar all-cause mortality trends is relevant for Canada. As this commentary highlights, the all-cause mortality shifts seen in the United States cannot be seen in Canada for either sex or age groups. The exact reasons for the differences between the two countries are not clear, but it is important for public health to further explore this question. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13011-016-0071-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4968006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49680062016-08-02 The impact of prescription opioids on all-cause mortality in Canada Imtiaz, Sameer Rehm, Jürgen Subst Abuse Treat Prev Policy Commentary An influential study from the United States generated considerable discussion and debate. This study documented rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century, with clear linkages of all-cause mortality to increasing rates of poisonings, suicides and chronic liver disease deaths. All of these causes of deaths are strongly related to the use of legal and illegal substances, but the study stressed the importance of prescription opioids. Given the similarities between the United States and Canada in prescription opioid use, the assessment of similar all-cause mortality trends is relevant for Canada. As this commentary highlights, the all-cause mortality shifts seen in the United States cannot be seen in Canada for either sex or age groups. The exact reasons for the differences between the two countries are not clear, but it is important for public health to further explore this question. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13011-016-0071-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-01 /pmc/articles/PMC4968006/ /pubmed/27476513 http://dx.doi.org/10.1186/s13011-016-0071-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Imtiaz, Sameer Rehm, Jürgen The impact of prescription opioids on all-cause mortality in Canada |
title | The impact of prescription opioids on all-cause mortality in Canada |
title_full | The impact of prescription opioids on all-cause mortality in Canada |
title_fullStr | The impact of prescription opioids on all-cause mortality in Canada |
title_full_unstemmed | The impact of prescription opioids on all-cause mortality in Canada |
title_short | The impact of prescription opioids on all-cause mortality in Canada |
title_sort | impact of prescription opioids on all-cause mortality in canada |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968006/ https://www.ncbi.nlm.nih.gov/pubmed/27476513 http://dx.doi.org/10.1186/s13011-016-0071-4 |
work_keys_str_mv | AT imtiazsameer theimpactofprescriptionopioidsonallcausemortalityincanada AT rehmjurgen theimpactofprescriptionopioidsonallcausemortalityincanada AT imtiazsameer impactofprescriptionopioidsonallcausemortalityincanada AT rehmjurgen impactofprescriptionopioidsonallcausemortalityincanada |